ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,619Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 99

$1.89M Total Retail Price of All Prescriptions

Rank: 2 out of 99

1,353 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 1,353 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 10,399 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$129 was the average price of a prescription from this provider, compared to $120 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SYNTHROID 804 616 1 2
SIMVASTATIN 705 561 2 8
INSULIN SYRINGE 533 292 3 6
NOVOLOG 532 273 4 10
METFORMIN HCL 531 387 5 3
LEVOTHYROXINE SODIUM 482 374 6 1
PEN NEEDLE 443 299 7 5
NIASPAN 385 284 8 62
NOVOLOG FLEXPEN 375 249 9 14
LANTUS 335 238 10 4
GLIMEPIRIDE 334 265 11 7
LANTUS SOLOSTAR 315 184 12 9
LISINOPRIL 310 188 13 11
CRESTOR 287 207 14 20
GLIPIZIDE ER 256 227 15 36
JANUVIA 248 192 16 15
LEVEMIR FLEXPEN 246 162 17 26
HUMALOG 227 133 18 12
LEVEMIR 219 140 19 51
VICTOZA 3-PAK 215 106 20 57
ATORVASTATIN CALCIUM 206 127 21 16
GLYBURIDE-METFORMIN HCL 181 144 R 22 65
AMLODIPINE BESYLATE 175 120 23 13
HYDROCHLOROTHIAZIDE 170 150 24 23
HUMULIN R 165 68 25 49
METFORMIN HCL ER 160 124 26 17
PRAVASTATIN SODIUM 146 96 27 18
LOSARTAN POTASSIUM 123 84 28 21
NOVOLOG MIX 70-30 120 87 29 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 99 30 38
ZETIA 111 98 31 47
DIOVAN 100 73 32 44
GABAPENTIN 99 67 33 22
LOVAZA 96 75 34 86
NOVOLOG MIX 70-30 FLEXPEN 92 68 35 31
LOSARTAN-HYDROCHLOROTHIAZIDE 86 80 36 46
JANUMET 85 64 37 33
GLIPIZIDE 85 65 37 25
GLIPIZIDE XL 84 68 39 56
VYTORIN 83 65 40 99
CARVEDILOL 79 62 41 28
HUMULIN N 78 59 42 42
METOPROLOL TARTRATE 76 51 43 39
OMEPRAZOLE 74 47 44 41
HUMALOG MIX 75-25 73 59 45 34
METHIMAZOLE 71 58 46 19
ALENDRONATE SODIUM 68 57 47 35
TESTOSTERONE CYPIONATE 67 37 S3 48 84
METOPROLOL SUCCINATE 66 35 49 37
LEVOXYL 65 29 50 30
HUMULIN 70-30 63 52 51 64
GLYBURIDE 61 56 R 52 54
SERTRALINE HCL 60 47 53 81
HYDROCORTISONE 59 25 54 48
ONGLYZA 58 43 55 58
LOVASTATIN 57 53 56 53
DIOVAN HCT 57 43 56 76
FUROSEMIDE 56 40 58 24
FENOFIBRATE 54 43 59 32
BYETTA 54 26 59 50
ALLOPURINOL 53 46 61 72
AMLODIPINE BESYLATE-BENAZEPRIL 50 49 62 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.